• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗线粒体疾病的工程遗传系统。

Engineering Genetic Systems for Treating Mitochondrial Diseases.

作者信息

Jang Yoon-Ha, Ahn Sae Ryun, Shim Ji-Yeon, Lim Kwang-Il

机构信息

Department of Chemical and Biological Engineering, Sookmyung Women's University, Yongsan-gu, Seoul 04310, Korea.

Industry Collaboration Center, Industry-Academic Cooperation Foundation, Sookmyung Women's University, Yongsan-gu, Seoul 04310, Korea.

出版信息

Pharmaceutics. 2021 May 28;13(6):810. doi: 10.3390/pharmaceutics13060810.

DOI:10.3390/pharmaceutics13060810
PMID:34071708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8227772/
Abstract

Mitochondria are intracellular energy generators involved in various cellular processes. Therefore, mitochondrial dysfunction often leads to multiple serious diseases, including neurodegenerative and cardiovascular diseases. A better understanding of the underlying mitochondrial dysfunctions of the molecular mechanism will provide important hints on how to mitigate the symptoms of mitochondrial diseases and eventually cure them. In this review, we first summarize the key parts of the genetic processes that control the physiology and functions of mitochondria and discuss how alterations of the processes cause mitochondrial diseases. We then list up the relevant core genetic components involved in these processes and explore the mutations of the components that link to the diseases. Lastly, we discuss recent attempts to apply multiple genetic methods to alleviate and further reverse the adverse effects of the core component mutations on the physiology and functions of mitochondria.

摘要

线粒体是参与各种细胞过程的细胞内能量产生器。因此,线粒体功能障碍常常导致多种严重疾病,包括神经退行性疾病和心血管疾病。更好地理解线粒体功能障碍背后的分子机制将为如何减轻线粒体疾病症状并最终治愈它们提供重要线索。在本综述中,我们首先总结控制线粒体生理和功能的遗传过程的关键部分,并讨论这些过程的改变如何导致线粒体疾病。然后,我们列出参与这些过程的相关核心遗传成分,并探索与疾病相关的成分突变。最后,我们讨论最近应用多种遗传方法来减轻并进一步逆转核心成分突变对线粒体生理和功能的不利影响的尝试。

相似文献

1
Engineering Genetic Systems for Treating Mitochondrial Diseases.用于治疗线粒体疾病的工程遗传系统。
Pharmaceutics. 2021 May 28;13(6):810. doi: 10.3390/pharmaceutics13060810.
2
Recent Advances in Mitochondria-Targeted Gene Delivery.线粒体靶向基因传递的最新进展。
Molecules. 2018 Sep 11;23(9):2316. doi: 10.3390/molecules23092316.
3
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
4
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders.大脑代谢在认知障碍和神经精神障碍中的新兴作用。
Neurosci Biobehav Rev. 2022 Nov;142:104892. doi: 10.1016/j.neubiorev.2022.104892. Epub 2022 Sep 28.
5
Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects.神经退行性疾病中的线粒体功能障碍:在疾病发病机制中的作用、分析策略及治疗前景
Neural Regen Res. 2022 Apr;17(4):754-758. doi: 10.4103/1673-5374.322430.
6
mtDNA Heteroplasmy at the Core of Aging-Associated Heart Failure. An Integrative View of OXPHOS and Mitochondrial Life Cycle in Cardiac Mitochondrial Physiology.线粒体DNA异质性是衰老相关心力衰竭的核心。对心脏线粒体生理学中氧化磷酸化和线粒体生命周期的综合观点。
Front Cell Dev Biol. 2021 Feb 22;9:625020. doi: 10.3389/fcell.2021.625020. eCollection 2021.
7
Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.线粒体、氧化应激与犬尿氨酸系统,兼论衰老与神经保护
Molecules. 2018 Jan 17;23(1):191. doi: 10.3390/molecules23010191.
8
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.线粒体在神经退行性疾病中的作用:阿尔茨海默病和帕金森病的启示。
Mol Neurobiol. 2020 Jul;57(7):2959-2980. doi: 10.1007/s12035-020-01926-1. Epub 2020 May 22.
9
Stable transplantation of human mitochondrial DNA by high-throughput, pressurized isolated mitochondrial delivery.高通量、加压分离线粒体传递实现稳定的人线粒体 DNA 移植。
Elife. 2021 Jan 13;10:e63102. doi: 10.7554/eLife.63102.
10
Mitochondrial Heteroplasmy.线粒体异质性
Adv Exp Med Biol. 2017;982:577-594. doi: 10.1007/978-3-319-55330-6_30.

引用本文的文献

1
Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities.线粒体碱基编辑:治疗机会的最新进展。
Int J Mol Sci. 2023 Mar 18;24(6):5798. doi: 10.3390/ijms24065798.
2
Current advances in gene therapy of mitochondrial diseases.线粒体疾病的基因治疗新进展。
J Transl Med. 2022 Dec 5;20(1):562. doi: 10.1186/s12967-022-03685-0.
3
Mitochondrial genome engineering coming-of-age.线粒体基因组工程时代的到来。

本文引用的文献

1
Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome.改造CRISPR/Cas9系统以靶向线粒体基因组。
Front Genet. 2021 Apr 6;12:627050. doi: 10.3389/fgene.2021.627050. eCollection 2021.
2
Mammalian mitochondrial DNA replication and mechanisms of deletion formation.哺乳动物线粒体 DNA 复制和缺失形成的机制。
Crit Rev Biochem Mol Biol. 2020 Dec;55(6):509-524. doi: 10.1080/10409238.2020.1818684. Epub 2020 Sep 24.
3
The Maintenance of Mitochondrial DNA Integrity and Dynamics by Mitochondrial Membranes.线粒体膜对线粒体DNA完整性和动态性的维持
Trends Genet. 2022 Aug;38(8):869-880. doi: 10.1016/j.tig.2022.04.011. Epub 2022 May 19.
4
Mitochondria-Targeted Drug Delivery.线粒体靶向药物递送
Pharmaceutics. 2022 Jan 13;14(1):178. doi: 10.3390/pharmaceutics14010178.
5
Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.线粒体脑肌病、乳酸酸中毒和卒中样发作的临床特征
Life (Basel). 2021 Oct 20;11(11):1111. doi: 10.3390/life11111111.
Life (Basel). 2020 Aug 26;10(9):164. doi: 10.3390/life10090164.
4
A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.一种细菌胞嘧啶脱氨酶毒素可实现无 CRISPR 的线粒体碱基编辑。
Nature. 2020 Jul;583(7817):631-637. doi: 10.1038/s41586-020-2477-4. Epub 2020 Jul 8.
5
High throughput single cell analysis of mitochondrial heteroplasmy in mitochondrial diseases.高通量单细胞分析线粒体疾病中线粒体异质性。
Sci Rep. 2020 Jul 2;10(1):10821. doi: 10.1038/s41598-020-67686-z.
6
Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.线粒体DNA异质性的治疗性调控:视角转变
Trends Mol Med. 2020 Jul;26(7):698-709. doi: 10.1016/j.molmed.2020.02.006. Epub 2020 Mar 26.
7
Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter.使用线粒体载体递送线粒体RNA对突变线粒体进行基因治疗的验证
Mol Ther Nucleic Acids. 2020 Jun 5;20:687-698. doi: 10.1016/j.omtn.2020.04.004. Epub 2020 Apr 19.
8
Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 gene.利用来自一名患有线粒体ND3基因突变的Leigh综合征患者的成纤维细胞对线粒体RNA治疗策略进行验证。
Sci Rep. 2020 May 5;10(1):7511. doi: 10.1038/s41598-020-64322-8.
9
TWINKLE and Other Human Mitochondrial DNA Helicases: Structure, Function and Disease.TWINKLE与其他人类线粒体DNA解旋酶:结构、功能与疾病
Genes (Basel). 2020 Apr 9;11(4):408. doi: 10.3390/genes11040408.
10
Mitochondrial targeting dendrimer allows efficient and safe gene delivery.线粒体靶向树枝状大分子可实现高效且安全的基因递送。
J Mater Chem B. 2014 May 7;2(17):2546-2553. doi: 10.1039/c3tb21348j. Epub 2013 Dec 23.